Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Urologic Oncology|July 11, 2026
Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysisHidetsugu Takahashi, Wataru Fukuokaya, Takafumi Yanagisawa, et al.
NPJ Precision Oncology|September 17, 2024
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinomaKazuki Nishimura, Kiyoshi Takahara, Kazumasa Komura, et al.
Cancer Diagnosis & Prognosis|May 11, 2023
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial CarcinomaTeruo Inamoto, Ryo Sato, Yuto Matsushita, et al.
Annals of Surgical Oncology|June 24, 2017
Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to NephrectomyTakuya Tsujino, Kazumasa Komura, Tomohisa Matsunaga, et al.
International Journal of Clinical Oncology|June 11, 2020
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world dataNobuyuki Hinata, Junji Yonese, Satoru Masui, et al.
World Journal of Urology|February 18, 2020
Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohortTomohisa Matsunaga, Kazumasa Komura, Takeshi Hashimoto, et al.
BMC Cancer|February 28, 2021
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~Takeshi Tsutsumi, Kazumasa Komura, Takeshi Hashimoto, et al.
Anticancer Research|May 27, 2026
Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell CarcinomaYuya Oishi, Yuto Matsushita, Shinya Watanabe, et al.
Annals of Surgical Oncology|June 27, 2019
The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in JapanKazumasa Komura, Takeshi Hashimoto, Takuya Tsujino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 30, 2023
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart reviewJunji Yonese, Nobuyuki Hinata, Satoru Masui, et al.
Pageof 19